Alumis (ALMS) Competitors

Alumis (NASDAQ:ALMS) and Chimerix (NASDAQ:CMRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability.

Which has higher valuation & earnings, ALMS or CMRX?

Alumis has higher earnings, but lower revenue than Chimerix.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alumis	N/A	N/A	N/A	N/A	N/A
Chimerix	$212K	3,778.71	-$82.10M	-$0.99	-8.63

Does the MarketBeat Community prefer ALMS or CMRX?

Chimerix received 374 more outperform votes than Alumis when rated by MarketBeat users. However, 100.00% of users gave Alumis an outperform vote while only 62.96% of users gave Chimerix an outperform vote.

Company	Underperform	Outperform
Alumis	Outperform Votes 22 100.00%	Underperform Votes No Votes
Chimerix	Outperform Votes 396 62.96%	Underperform Votes 233 37.04%

Do institutionals & insiders hold more shares of ALMS or CMRX?

45.4% of Chimerix shares are held by institutional investors. 13.1% of Chimerix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Do analysts rate ALMS or CMRX?

Alumis currently has a consensus price target of $25.86, indicating a potential upside of 524.57%. Chimerix has a consensus price target of $8.53, indicating a potential downside of 0.08%. Given Alumis' stronger consensus rating and higher probable upside, equities research analysts plainly believe Alumis is more favorable than Chimerix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alumis	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.22
Chimerix	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Is ALMS or CMRX more profitable?

Alumis' return on equity of 0.00% beat Chimerix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alumis	N/A	N/A	N/A
Chimerix	N/A	-50.78%	-44.94%

Does the media prefer ALMS or CMRX?

In the previous week, Alumis had 6 more articles in the media than Chimerix. MarketBeat recorded 11 mentions for Alumis and 5 mentions for Chimerix. Chimerix's average media sentiment score of 1.27 beat Alumis' score of 0.91 indicating that Chimerix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alumis	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Chimerix	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Alumis beats Chimerix on 8 of the 13 factors compared between the two stocks.